Compare AMAL PRODUCT with POLYLINK POL - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAL PRODUCT vs POLYLINK POL - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAL PRODUCT POLYLINK POL AMAL PRODUCT/
POLYLINK POL
 
P/E (TTM) x 81.5 43.7 186.6% View Chart
P/BV x 14.4 1.5 947.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AMAL PRODUCT   POLYLINK POL
EQUITY SHARE DATA
    AMAL PRODUCT
Mar-20
POLYLINK POL
Mar-21
AMAL PRODUCT/
POLYLINK POL
5-Yr Chart
Click to enlarge
High Rs17717 1,063.1%   
Low Rs796 1,248.8%   
Sales per share (Unadj.) Rs34.616.9 204.2%  
Earnings per share (Unadj.) Rs9.70.5 1,806.5%  
Cash flow per share (Unadj.) Rs10.70.9 1,170.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs27.111.1 243.4%  
Shares outstanding (eoy) m9.4322.11 42.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.70.7 545.3%   
Avg P/E ratio x13.121.3 61.6%  
P/CF ratio (eoy) x12.012.6 95.1%  
Price / Book Value ratio x4.71.0 457.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,207254 474.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1223 52.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m326374 87.1%  
Other income Rs m175 322.3%   
Total revenues Rs m343380 90.4%   
Gross profit Rs m13919 737.8%  
Depreciation Rs m98 104.2%   
Interest Rs m211 1,735.5%   
Profit before tax Rs m12715 855.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m353 1,202.7%   
Profit after tax Rs m9212 770.5%  
Gross profit margin %42.75.0 847.1%  
Effective tax rate %27.619.6 140.5%   
Net profit margin %28.23.2 884.7%  
BALANCE SHEET DATA
Current assets Rs m239126 189.7%   
Current liabilities Rs m4240 105.6%   
Net working cap to sales %60.423.0 262.5%  
Current ratio x5.73.2 179.6%  
Inventory Days Days2203 6,786.0%  
Debtors Days Days80729 11.0%  
Net fixed assets Rs m144168 85.5%   
Share capital Rs m94111 85.2%   
"Free" reserves Rs m161135 119.0%   
Net worth Rs m255246 103.8%   
Long term debt Rs m324 771.4%   
Total assets Rs m383294 130.2%  
Interest coverage x7.013.3 53.1%   
Debt to equity ratio x0.10 743.1%  
Sales to assets ratio x0.91.3 66.9%   
Return on assets %29.54.5 659.9%  
Return on equity %36.04.9 742.2%  
Return on capital %51.56.4 801.7%  
Exports to sales %029.5 0.0%   
Imports to sales %02.7 0.0%   
Exports (fob) Rs mNA110 0.0%   
Imports (cif) Rs mNA10 0.0%   
Fx inflow Rs m0110 0.0%   
Fx outflow Rs m010 0.0%   
Net fx Rs m0100 0.0%   
CASH FLOW
From Operations Rs m1453 5,253.6%  
From Investments Rs m-47-12 395.7%  
From Financial Activity Rs m-947 -1,319.6%  
Net Cashflow Rs m4-2 -221.0%  

Share Holding

Indian Promoters % 66.2 75.0 88.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 25.0 135.1%  
Shareholders   13,629 5,196 262.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAL PRODUCT With:   VENLON POLY.  TANFAC INDUSTRIES  PAR DRUGS AND CHEMICALS  RESONANCE SPEC.  TATVA CHINTAN PHARMA  



Today's Market

Sensex Trades Lower Tracking Weak Global Cues; IT & Energy Stocks Under Pressure(10:30 am)

Asian share markets are trading mostly lower today with lingering worries over a US rate hike partly offset by potentially positive news on the severity of the Omicron coronavirus variant.

Related Views on News

Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)

Sep 14, 2021

Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?

Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)

Aug 24, 2021

The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.

Understanding Aarti Industries' Demerger (Views On News)

Aug 20, 2021

Will the pharma unit's demerger unlock value for shareholders?

What Next for Devyani, Zomato, & Tatva Chintan Pharma After Stellar IPO Gains? (Views On News)

Aug 20, 2021

What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?

Pidilite Results Review: Net Profit Spikes as Sales Rise 121% (Views On News)

Aug 12, 2021

Pidilite posts strong sales growth and a multi-fold jump in bottomline.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAL PRODUCT SHARE PRICE


Dec 6, 2021 11:05 AM

TRACK AMAL PRODUCT

  • Track your investment in AMAL PRODUCT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAL PRODUCT 5-YR ANALYSIS

COMPARE AMAL PRODUCT WITH

MARKET STATS